A definitive diagnosis of T-cell lymphoma may be contingent on the rearrang
ement profile of the T-cell receptor. This is most accurately done by molec
ular analysis of the beta-chain of the T-cell receptor (TCR beta) by Southe
rn blotting hybridization that requires unfixed tissue. We describe a rever
se transcriptase in situ PCR (RT in situ PCR) method that permits the targe
t-specific direct incorporation of the reporter nucleotide into the differe
nt transcripts that comprise the TCR beta, using paraffin-embedded, formali
n-fixed tissue. Each of the 25 possible V beta segment rearrangments was do
cumented in three lymph nodes with nonspecific lymphadenitis with clonal ex
pansion evident in a case of metastatic melanoma. Monoclonal expression was
documented in seven tissues diagnostic of a T-cell lymphoma. We analyzed f
ive additional tissues for which a definitive diagnosis of T-cell vs B-cell
lymphoma could not be rendered on the basis of histological, immunohistolo
gical, and flow cytometric analysis. RT in situ PCR for TCR beta expression
with CD3 colabeling demonstrated which of these lesions was a B-cell-rich
T-cell lymphoma. We conclude that the RT in situ PCR methodology will allow
the routine determination of monoclonal vs multiclonal expression patterns
of the TCR beta using archival paraffin-embedded tissues.